Treating seizures using ICE inhibitors

Details for Australian Patent Application No. 2005247409 (hide)

Owner Vertex Pharmaceuticals Incorporated

Inventors Vezzani, Annamaria; Randle, John C.R.

Agent Cullens

Pub. Number AU-B-2005247409

PCT Pub. Number WO2005/115362

Priority 60/571,314 15.05.04 US

Filing date 16 May 2005

Wipo publication date 8 December 2005

Acceptance publication date 10 November 2011

International Classifications

A61K 31/00 (2006.01)

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/4025 (2006.01) - not condensed and containing further heterocyclic rings, e.g. cromakalim

A61K 31/551 (2006.01) - having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep

A61K 38/05 (2006.01) Medicinal preparations containing peptides - Dipeptides

A61P 25/08 (2006.01) Drugs for disorders of the nervous system

Event Publications

4 January 2007 PCT application entered the National Phase

  PCT publication WO2005/115362 Priority application(s): WO2005/115362

10 November 2011 Application Accepted

  Published as AU-B-2005247409

8 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005247410-Methods , systems and devices for noninvasive pulmonary delivery

2005247405-Androgen receptor modulators and method of treating disease using the same